整合FDG PET影像组学特征对结直肠癌肝转移患者进行预后建模
研究纳入52例仅肝内转移的结直肠癌患者,基于FDG PET图像提取容积与异质性等参数构建单变量及多变量预后模型,预测总生存、无进展生存和事件无生存。常用SUV指标预测能力较差,肝转移灶数目、代谢肿瘤体积与总病灶糖酵解表现较好,多变量模型进一步改善预测(OS的HR 4.29,P=0.00004)。
要点
- 肝转移灶数目与代谢肿瘤体积的预后预测优于常用SUV指标。
- 多变量模型整合异质性特征后预测能力进一步提升(OS的HR 4.29,P=0.00004)。
- SUVmax与SUVpeak在各预测任务中表现相对较差。
核心结论
- 超越常用SUV参数的PET衍生指标在改善肝转移患者临床结局预测方面具有显著潜力,尤其采用多变量模型时。
研究设计与样本
- 预后建模研究,纳入52例仅肝内转移的结直肠癌患者(29男、23女;平均年龄62.9岁,SD 9.8,范围32-82),于最终治疗决策前临床检查中行PET/CT,提取FDG PET容积与异质性等参数,采用单变量和多变量模型并纳入统计考量以抑制假发现和过拟合,用Kaplan-Meier分析和Cox比例风险回归计算HR。
诊断标准与关键数值
- SUVmax对OS、PFS、EFS的HR分别为1.48、0.83、1.16;SUVpeak分别为2.05、1.93、1.64;肝转移灶数目分别为2.71、2.61、2.42;MTV分别为2.62、1.96、2.29;TLG表现与MTV相似;多变量模型对OS、PFS、EFS的HR分别为4.29、4.02、3.20(P值分别为0.00004、0.0019、0.0002)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: We aimed to improve prediction of outcome for patients with colorectal liver metastases, via prognostic models incorporating PET-derived measures, including radiomic features that move beyond conventional standard uptake value (SUV) measures.
PATIENTS AND METHODS: A range of parameters including volumetric and heterogeneity measures were derived from FDG PET images of 52 patients with colorectal intrahepatic-only metastases (29 males and 23 females; mean age 62.9 years [SD 9.8; range 32-82]). The patients underwent PET/CT imaging as part of the clinical workup prior to final decision on treatment. Univariate and multivariate models were implemented, which included statistical considerations (to discourage false discovery and overfitting), to predict overall survival (OS), progression-free survival (PFS) and event-free survival (EFS). Kaplan-Meier survival analyses were performed, where the subjects were divided into high-risk and low-risk groups, from which the hazard ratios (HR) were computed via Cox proportional hazards regression.
RESULTS: Commonly-invoked SUV metrics performed relatively poorly for different prediction tasks (SUVmax HR = 1.48, 0.83 and 1.16; SUVpeak HR = 2.05, 1.93, and 1.64, for OS, PFS and EFS, respectively). By contrast, the number of liver metastases and metabolic tumor volume (MTV) each performed well (with respective HR values of 2.71, 2.61 and 2.42, and 2.62, 1.96 and 2.29, for OS, PFS and EFS). Total lesion glycolysis (TLG) also resulted in similar performance as MTV. Multivariate prognostic modeling incorporating different features (including those quantifying intra-tumor heterogeneity) resulted in further enhanced prediction. Specifically, HR values of 4.29, 4.02 and 3.20 (p-values = 0.00004, 0.0019 and 0.0002) were obtained for OS, PFS and EFS, respectively.
CONCLUSIONS: PET-derived measures beyond commonly invoked SUV parameters hold significant potential towards improved prediction of clinical outcome in patients with liver metastases, especially when utilizing multivariate models.
引用
- Rahmim A, Bak-Fredslund KP, Ashrafinia S, et al. Prognostic modeling for patients with colorectal liver metastases incorporating FDG PET radiomic features. Eur J Radiol. 2019. PMID: 30927933. doi:10.1016/j.ejrad.2019.02.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。